Abstract
Thrombotic thrombocytopenic purpura (TTP) is a serious disorder of unknown etiology. Clinical findings are the result of vascular occlusions by platelet aggregates. Treatment with plasma exchange, often used in combination with corticosteroids, vincristine, aspirin, and dipyridamole, has reduced mortality to 20%. Relapses may occur even after long disease-free intervals. In this report we describe our experience with splenectomy in patients with relapsing TTP. Between July 1978 and March 1994, 16 patients with TTP were treated in our hospital. Five of the 13 patients surviving the first episode of TTP had relapses. Most relapses were treated as the first episode of TTP with plasma exchange with fresh-frozen plasma, followed by plasma infusions, corticosteroids, and vincristine. Sometimes aspirin and dipyridamole were added. Splenectomy was performed after five relapses in the first two patients and after two and three relapses in the other patients. Before splenectomy the disease-free interval varied from 3 weeks to 27 months and the incidence rate of relapses was 1.5 relapse/patient/year. None of the patients had relapses after splenectomy. The mean follow-up after splenectomy is 39 months with a range of 9–62 months. We conclude that patients with relapsing TTP can benefit from splenectomy, since it seems to increase disease-free intervals. Further investigation is necessary to understand the role of the spleen in the pathogenesis of TTP.
Similar content being viewed by others
References
Amorosi EL, Ultman JE (1994) Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine (Baltimore) 45:139–159
Baehr G, Klemperer P, Schifrin A (1936) An acute febrile anemia and thrombotic thrombocytopenic purpura with diffuse platelet thrombosis of capillaries and arterioles. Trans Am Phys 51:43–48
Bell WR, Braine HG, Ness PM, Kickler TS (1991) Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325:398–403
Bernard RP, Bauman AW, Schwartz SI (1969) Splenectomy for thrombotic thrombocytopenic purpura. Ann Surg 169:616–624
Bukowski RM (1982) Thrombotic thrombocytopenic purpura: a review. Prog Hemost Thromb 6:287–337
Bukowski RM, Hewlett JS, Reimer RR, Groppe CW, Weik JK, Livingstone RB (1981) Therapy of thrombotic thrombocytopenic purpura: an overview. Semin Thromb Hemost 7:1–8
Crain SM, Choudhury AM (1980) Thrombotic thrombocytopenic purpura in a splenectomized patient with Hodgkin's disease. Am J Med Sci 280:35–40
Cuttner (1980) Thrombotic thrombocytopenic purpura: a ten-year experience. Blood 56:302–306
Del Zoppo GJ (1987) Antiplatelet therapy in thrombotic thrombocytopenic purpura. Semin Hematol 24:130–139
Eldor A, Moser AM, Rose M, Ben-Yehuda D, Rachmilewitz EA (1992) Thrombotic thrombocytopenic purpura: the Israeli experience. Transf Sci 13:53–57
Garg M, Kaplan AM, Subbarao B (1994) Cellular basis of differential responsiveness of lymph nodes and spleen to 23-valent Pnu-Imune vaccine. J Immunol 152:1589–1596
Gutterman LA, Stevenson TD (1982) Treatment of thrombotic thrombocytopenic purpura with vincristine. JAMA 247: 1433–1436
Henon P (1992) Thrombotic thrombocytopenic purpura: clinical results of a French Controlled trial. Transfus Sci 13:63–72
Howard DJ, Roberts AB, Page FT (1975) Late recurrence of thrombotic thrombocytopenic purpura after splenectomy. Br Med J 2:317
Kadri A, Moinuddin M, de Leeuw NKM (1975) Phagocytosis of blood cells by splenic macrophages in thrombotic thrombocytopenic purpura. Ann Intern Med 82:799–802
Kennedy SS, Zacharski LR, Beck JR (1980) Thrombotic thrombocytopenic purpura: analysis of 48 unselected cases. Semin Thromb Hemost 6:341–349
Kitchens CS (1982) Studies of a patient with recurring thrombotic thrombocytopenic purpura. Am J Hematol 13:259–267
Liu ET, Linker CA, Schuman MA (1986) Management of treatment failures in thrombotic thrombocytopenic purpura. Am J Hematol 23:347–361
Meacham GC, Orbison JL, Heinle RW et al (1951) Thrombotic thrombocytopenic purpura, a disseminated disease of arterioles. Blood 6:706–719
Moake JL (1994) Haemolytic-uraemic syndrome: basic science. Lancet 343:393–397
Onundarson PT, Rowe JM, Heal JM, Francis CW (1992) Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution. Arch Intern Med 152:791–796
Reynolds PM, Jackson JM, Brine JAS, Vivian AB (1976) Thrombotic thrombocytopenic purpura Remission following splenectomy. Report of a case and review of the literature. Am J Med 61:439–447
Rock GA, Shuman KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393–397
Rose M, Eldor A (1987) High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. Am J Med 83:437–444
Rosove MH, Bhuta S (1985) Splenectomy and extravascular platelet destruction in thrombotic thrombocytopenic purpura. Arch Intern Med 145:937–939
Rowe JM, Francis CW, Cyran EM, Marder VJ (1985) Thrombotic thrombocytopenic purpura: recovery after splenectomy associated with persistance of abnormally large von Willebrand factor multimers. Am J Hematol 20:161–168
Rutkow IM (1978) Thrombotic thrombocytopenic purpura (TTP) and splenectomy: a current appraisal. Ann Surg 188: 701–705
Saracco SM, Farhi DC (1990) Splenic pathology in thrombotic thrombocytopenic purpura. Am J Surg Pathol 14:223–229
Schneider PA, Rayner AA, Linker CA, Schuman MA, Liu ET, Hohn DC (1985) The role of splenectomy in the multimodality treatment of thrombotic thrombocytopenic purpura. Ann Surg 202:318–322
Schreeder MT, Prchal JT (1986) Treatment of thrombotic thrombocytopenic by vincristine. Am J Hematol 14:75–76
Sennett ML, Conrad ME (1986) Treatment of thrombotic thrombocytopenic purpura: plasmapheresis, plasma infusion, and vincristine. Arch Intern Med 146:266–267
Talarico L, Grapski R, Lutz CK, Weintraub LR (1987) Late postsplenectomy recurrence of thrombotic thrombocytopenic purpura responding to removal of an accessory apleen. Am J Med 82:845–848
Thompson CE, Damon LE, Ries CA, Linker CA (1992) Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 80:1890–1895
Wolf BC, Neiman RS (1989) Non-neoplastic vascular lesions. In: Wolf BC, Neiman RS (eds) Disorders of the spleen. WB Saunders, Philadelphia, pp 185–186
Zacharski LR, Lusted D, Glick JL (1976) Thrombotic thrombocytopenic purpura in a previously splenectomized patient. Am J Med 60:1061–1063
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Veltman, G.A.M., Brand, A., Leeksma, O.C. et al. The role of splenectomy in the treatment of relapsing thrombotic thrombocytopenic purpura. Ann Hematol 70, 231–236 (1995). https://doi.org/10.1007/BF01784041
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01784041